Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Novel agents for urinary incontinence and renal disorders imparted in recent patents

April 27, 2005

Theravance presents novel agents for overactive bladder

April 22, 2005

Fast track designation for terlipressin in type 1 hepatorenal syndrome

April 22, 2005

Greater efficacy found with a duloxetine/PFMT combination in women with SUI

April 22, 2005

Kentera begins European roll-out

April 20, 2005

New phase III data on the efficacy of fesoterodine in OAB

April 20, 2005

SPI-153 enters phase II trial for BPH

April 18, 2005

5-HT2C agonists evaluated as therapeutics for urinary disorders

April 15, 2005

Toray and Takeda to jointly develop compound for frequent urination

April 11, 2005

Recent Roche patents describe therapeutic agents for genitourinary disorders

April 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Roche secures CE mark for Alzheimer’s blood test
BioWorld
Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...